[Ecstasy poisoning in a 10-month-old infant]

Area of Science:

• Pediatric Toxicology
• Emergency Medicine
• Clinical Case Reports

Background:

• Ecstasy (3,4-methylenedioxymethamphetamine) use is increasingly prevalent beyond recreational settings.
• The domestic environment poses a risk for accidental pediatric exposure to illicit substances.
• Pediatric ecstasy poisoning is rare, with limited case reports available.

Observation:

• A 10-month-old infant presented with acute behavioral disturbances, including restlessness, hypertonia, and repetitive movements.
• Clinical manifestations included significant tachycardia, hypertension, agitation, mydriasis, and nystagmus.
• Differential diagnoses such as febrile seizures, cranial trauma, and encephalitis were systematically excluded.

Findings:

• Urinary toxicological screening confirmed the presence of methamphetamine, the primary metabolite of MDMA.
• Gas chromatography/mass spectrometry identified MDMA and caffeine in the infant's urine.
• The infant experienced a complete clinical recovery by the following morning.

Implications:

• This case underscores the potential for severe accidental drug poisoning in infants due to evolving substance use patterns.
• Increased awareness is needed regarding the accessibility of ecstasy in domestic environments.
• Prompt emergency department evaluation and toxicological analysis are crucial for managing pediatric drug ingestions.